Quest Diagnostics Incorporated

Secaucus, NJ

UEI
UC5SPMUJF8V3
CAGE
1FHB9
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
Corporate family
SAM.gov registration date
Physical address
500 Plaza Dr, Secaucus, NJ 07094, USA
Founded
1967
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $4,739,833
FY2026 $60,114,042
FY2025 $49,528,301
FY2024 $101,341,296
FY2023 $140,514,507

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $105,278,107
2 Department of Justice $4,357,888
3 Department of the Army $40,000
4 Air Force $40,000

Contract vehicles

Expired vehicles (1)

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
Life Technologies Corporation WOMEN'S HEALTH INITIATIVE (WHI) - CLINICAL COORDINATING CENTER (CCC). ExamOne will conduct home exams and collect the biomarker component for the Long Life… 75N92021F00001 $255,437

Grant subawards

Prime recipient Prime award Amount Awarded
Fred Hutchinson Cancer Center ExamOne has been engaged to conduct home exams and collect the biomarker component for the Long Life Study 2 (LLS2) project for the Fred Hutchinson Cancer… U01CA173642 $200,000
The Regents Of The University Of California. San Francisco Responsibilities of ExamOne: ExamOne, a wholly owned subsidiary of Quest Diagnostics, will perform the mobile specimen collection services as follows: 1.… R56AG075744 $131,200

Similar vendors

Vendor Location Primary NAICS
Labcorp UEI SXDFLBD5JFP3 Burlington, NC 621511 Medical Laboratories
MD UEI RRGLZJC5DBE6 Berkeley, CA 621511 Medical Laboratories
Arup Laboratories Inc. UEI NLTPT1KJARJ7 Salt Lake City, UT 621511 Medical Laboratories
Neogenomics Laboratories, Inc. UEI ML9LFC5CK7K9 Fort Myers, FL 541380 Testing Laboratories and Services
Boca Biolistics, LLC UEI N4ZKFS6ET6J4 Pompano Beach, FL 238990 All Other Specialty Trade Contractors

About the company

Quest Diagnostics Incorporated, doing business as Quest Diagnostics, operates as a large for-profit clinical laboratory testing company based in Secaucus, New Jersey, delivering reference laboratory testing, clinical diagnostic analysis, and specialized medical laboratory services to federal agencies as a prime contractor with no set-aside designations, competing full-and-open across its federal portfolio. The vendor is not a small business and holds no SBA certifications; it operates as a pure prime contractor on federal service contracts with minimal subcontractor engagement and does not appear as a named sub on defense or civilian contracts of note.

Quest Diagnostics dominates federal medical laboratory testing procurement through the GSA Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), which anchors the majority of its federal work. The source describes 4,961 task orders across this single parent vehicle carrying $1.47 billion in combined potential value—a platform that reaches across the Department of Veterans Affairs, Bureau of Prisons, Indian Health Service, Department of Health and Human Services, National Institutes of Health, and dozens of other federal agencies. On this schedule, Quest delivers reference laboratory testing, infectious disease screening, clinical diagnostic analysis, esoteric and specialized testing, and specimen courier services to federal healthcare systems. Representative recent contract work includes a $3.5 million delivery order from the VA Strategic Acquisition Center Frederick for hematology molecular testing services (September 2026), a $4.074 million delivery order from VISN 12 for reference laboratory testing services during an electronic health record transition (July 2026), multiple million-dollar BPA calls from VISN 17, VISN 6, and VISN 21 for regional reference laboratory services, and $125,000 delivery order with the National Heart, Lung and Blood Institute for laboratory services to research participants on NHLBI clinical protocols (January 2026). Quest also holds recent single-award indefinite delivery contracts: a $40 million IDIQ with VISN 5 for Eastern Region reference laboratory testing (October 2026, five-year performance through September 2031) and a $49 million IDIQ with VISN 19 for reference laboratory testing across Phoenix, Los Angeles, San Diego, Tucson, and Arizona/New Mexico regions (September 2026, five-year performance through August 2031).

Customer concentration is deep within the Department of Veterans Affairs. The top five customer agencies by potential value—all VA VISNs—account for 22% of combined potential value: VISN 8 ($264.8 million across 148 awards), VISN 21 ($238.1 million / 148 awards), VISN 6 ($214.3 million / 123 awards), VISN 17 ($167.2 million / 125 awards), and VISN 15 ($166.3 million / 134 awards). By award count, the top five agencies (20% of all awards) are the Indian Health Service (418 awards, $45.7 million), Army Medical Command (321 awards, $20.2 million), Army (317 awards, $19.4 million), Department of Veterans Affairs broadly (152 awards, $13.5 million), and Bureau of Prisons Terminal Island facility (150 awards, $1.5 million). The VA's dominance by dollar value but not by raw count signals that Quest holds several large indefinite delivery vehicles with VA networks while fulfilling many smaller monthly or quarterly task orders at BOP facilities. Activity has declined year over year—from 538 awards in 2022 to 265 in 2026 (through October 1)—though combined potential value remains substantial at $4.82 billion across all time periods. Seventy-six awards face ultimate completion within the next twenty-four months, carrying $75.2 million in combined potential value and therefore representing recompete exposure.

The Medical Laboratory Testing and Analysis Services Federal Supply Schedule, a GSA master contract vehicle, dominates Quest's federal parent vehicle position: 4,993 task orders worth $1.47 billion. Two legacy BPAs with the Bureau of Prisons also remain active: BPA 15BNAS20A00000070 (1,540 task orders, $87.9 million) and BPA 15BNAS20A00000138 (87 task orders, $1.5 million). Two Army IDIQs—DADA1003D0030 (266 task orders, $41.1 million) and DADA1098D0001 (216 task orders)—represent secondary vehicle positions. Quest operates exclusively or nearly exclusively as a prime contractor; across all awards, the vendor holds prime status on 6,852 of 6,855 awards (100%), with only three sub-awards recorded (two federal contract subs to Life Technologies and Fred Hutchinson Cancer Center as prime grantees, 2024). On Service Contract Inventory-reportable federal service contracts (prime records, FY2022–FY2025), Quest reported $288.3 million in invoiced revenue across 411 contracts: FY2022 $141.8 million (341 FTEs), FY2023 $57 million (137 FTEs), FY2024 $61.3 million (145 FTEs), and FY2025 $28.1 million (65.7 FTEs). SCI-captured hourly rates cluster tightly around $200/hour (10th percentile $199.96/hr, median $200.00/hr, 90th percentile $200.06/hr), indicating standardized federal pricing across federal service contracts. Subcontractor hours represent 0% share of total contractor hours across prime contracts, confirming Quest Diagnostics builds its own delivery infrastructure rather than teaming with or feeding to other federal contractors.

The corporate structure includes 24 named subsidiaries. The source identifies Quest Diagnostics Nichols Institute (a for-profit clinical laboratory), Ameripath Inc. (a for-profit entity self-certified as a HUBZone Joint Venture), Focus Diagnostics Inc. (manufacturer of goods), Hemocue Inc., and Quest Diagnostics TB LLC, among others. Subsidiary names carry clinical and diagnostic framing but do not alter the vendor's primary profile: a vertically integrated, large-scale medical laboratory testing company delivering reference laboratory services, infectious disease screening, and clinical diagnostic analysis to federal healthcare agencies without reliance on set-asides or subcontractor partnerships. Quest Diagnostics' federal footprint reflects its position as the dominant reference laboratory testing provider to the Veterans Health Administration and a major supplier to Bureau of Prisons, Indian Health Service, and civilian federal agencies' healthcare operations.

Quick answers

Is Quest Diagnostics Incorporated registered in SAM.gov?

Yes. Quest Diagnostics Incorporated's SAM.gov registration is active through April 2, 2027.

Which contract vehicles does Quest Diagnostics Incorporated hold?

Quest Diagnostics Incorporated holds a place on 2 federal contract vehicles, including Test Surge and Data Sharing.

How much has Quest Diagnostics Incorporated received in federal contracts?

Federal contracts obligated $49,528,301 to Quest Diagnostics Incorporated in fiscal year 2025 and $356,237,978 in fiscal years 2023 through 2027.

How does Quest Diagnostics Incorporated rank among federal contractors?

Quest Diagnostics Incorporated ranked #1 in PSC H166, #2 in NAICS 6215 and #2 in PSC Q3 in FY2025.

What is Quest Diagnostics Incorporated's most recent federal award?

Quest Diagnostics Incorporated's most recent federal contract award is Reference lab testing services (36C25727N0096), from Veterans Integrated Service Network 17 (VHA), on January 1, 2027.

On GovTribe

See Quest Diagnostics Incorporated's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors